These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26047084)

  • 1. Letter to the Editor: Re: Neurobehavioral Deficits, Diseases, and Associated Costs of Exposure to Endocrine-Disrupting Chemicals in the European Union.
    Middelbeek RJ; Veuger SA
    J Clin Endocrinol Metab; 2015 Jun; 100(6):L52-3. PubMed ID: 26047084
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to the Letter by Middlebeek and Veuger.
    Bellanger M; Demeneix B; Grandjean P; Zoeller RT; Trasande L
    J Clin Endocrinol Metab; 2015 Jun; 100(6):L54-5. PubMed ID: 26047085
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurobehavioral deficits, diseases, and associated costs of exposure to endocrine-disrupting chemicals in the European Union.
    Bellanger M; Demeneix B; Grandjean P; Zoeller RT; Trasande L
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1256-66. PubMed ID: 25742515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union.
    Trasande L; Zoeller RT; Hass U; Kortenkamp A; Grandjean P; Myers JP; DiGangi J; Bellanger M; Hauser R; Legler J; Skakkebaek NE; Heindel JJ
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1245-55. PubMed ID: 25742516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union.
    Legler J; Fletcher T; Govarts E; Porta M; Blumberg B; Heindel JJ; Trasande L
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1278-88. PubMed ID: 25742518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.
    Hauser R; Skakkebaek NE; Hass U; Toppari J; Juul A; Andersson AM; Kortenkamp A; Heindel JJ; Trasande L
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1267-77. PubMed ID: 25742517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis.
    Trasande L; Zoeller RT; Hass U; Kortenkamp A; Grandjean P; Myers JP; DiGangi J; Hunt PM; Rudel R; Sathyanarayana S; Bellanger M; Hauser R; Legler J; Skakkebaek NE; Heindel JJ
    Andrology; 2016 Jul; 4(4):565-72. PubMed ID: 27003928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Female Reproductive Disorders, Diseases, and Costs of Exposure to Endocrine Disrupting Chemicals in the European Union.
    Hunt PA; Sathyanarayana S; Fowler PA; Trasande L
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1562-70. PubMed ID: 27003299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cost burden of exposure to endocrine disrupting chemicals. A critical review.
    Bond GG; Dietrich DR
    Arch Toxicol; 2017 Aug; 91(8):2745-2762. PubMed ID: 28528477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis.
    Attina TM; Hauser R; Sathyanarayana S; Hunt PA; Bourguignon JP; Myers JP; DiGangi J; Zoeller RT; Trasande L
    Lancet Diabetes Endocrinol; 2016 Dec; 4(12):996-1003. PubMed ID: 27765541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of methods for calculating the health costs of endocrine disrupters: a case study on triclosan.
    Prichystalova R; Fini JB; Trasande L; Bellanger M; Demeneix B; Maxim L
    Environ Health; 2017 Jun; 16(1):55. PubMed ID: 28599657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impacts of environmentally attributable childhood health outcomes in the European Union.
    Bartlett ES; Trasande L
    Eur J Public Health; 2014 Feb; 24(1):21-6. PubMed ID: 23748596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk assessment of endocrine disrupting chemicals--introduction to this special issue.
    van Ravenzwaay B; Dekant W; Vrijhof H
    Toxicol Lett; 2013 Dec; 223(3):269-70. PubMed ID: 24140152
    [No Abstract]   [Full Text] [Related]  

  • 14. ECETOC Florence workshop on risk assessment of endocrine substances, including the potency concept.
    Fegert I
    Toxicol Lett; 2013 Dec; 223(3):310-4. PubMed ID: 23558296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to endocrine disrupting chemicals and neurodevelopmental alterations.
    Pinson A; Bourguignon JP; Parent AS
    Andrology; 2016 Jul; 4(4):706-22. PubMed ID: 27285165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of research on endocrine disruption for the environmental risk assessment, regulation and monitoring of chemicals in the European Union.
    Matthiessen P; Johnson I
    Environ Pollut; 2007 Mar; 146(1):9-18. PubMed ID: 16996184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculation of the disease burden associated with environmental chemical exposures: application of toxicological information in health economic estimation.
    Grandjean P; Bellanger M
    Environ Health; 2017 Dec; 16(1):123. PubMed ID: 29202828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health risk assessment procedures for endocrine disrupting compounds within different regulatory frameworks in the European Union.
    Beronius A; Rudén C; Hanberg A; Håkansson H
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):111-22. PubMed ID: 19500631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary exposure to endocrine-active pesticides: Conflicting opinions in a European workshop.
    Flynn K
    Environ Int; 2011 Jul; 37(5):980-90. PubMed ID: 21497907
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to A critique of the European Commission Document, "State of the Art Assessment of Endocrine Disrupters" by Rhomberg and colleagues--letter to the editor.
    Kortenkamp A; Martin O; Evans R; Orton F; McKinlay R; Rosivatz E; Faust M
    Crit Rev Toxicol; 2012 Oct; 42(9):787-9; author reply 790-1. PubMed ID: 22900988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.